Snowflake (NYSE:SNOW – Get Free Report) had its price target increased by research analysts at Piper Sandler from $295.00 to $320.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Piper Sandler’s price target indicates a potential upside of 29.90% from the company’s previous close.
SNOW has been the subject of a number of other reports. Benchmark increased their price objective on Snowflake from $200.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Morgan Stanley increased their price objective on Snowflake from $245.00 to $300.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Royal Bank Of Canada increased their price objective on Snowflake from $220.00 to $284.00 and gave the company an “outperform” rating in a report on Thursday, May 28th. Loop Capital increased their price objective on Snowflake from $290.00 to $320.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Monness Crespi & Hardt increased their price objective on Snowflake from $282.00 to $320.00 and gave the company a “buy” rating in a report on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, thirty-five have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $288.62.
Read Our Latest Analysis on Snowflake
Snowflake Trading Down 5.7%
Snowflake (NYSE:SNOW – Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.32 by $0.07. The business had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.32 billion. Snowflake had a negative return on equity of 50.50% and a negative net margin of 23.79%.Snowflake’s quarterly revenue was up 33.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.24 earnings per share. Analysts forecast that Snowflake will post -2.15 EPS for the current year.
Insiders Place Their Bets
In other Snowflake news, Director Mark Garrett sold 100,000 shares of the stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $250.00, for a total transaction of $25,000,000.00. Following the completion of the sale, the director directly owned 8,801 shares in the company, valued at approximately $2,200,250. This trade represents a 91.91% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Christian Kleinerman sold 5,000 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $236.77, for a total value of $1,183,850.00. Following the sale, the executive vice president owned 528,494 shares of the company’s stock, valued at approximately $125,131,524.38. The trade was a 0.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,416,489 shares of company stock valued at $310,023,119. 4.80% of the stock is currently owned by insiders.
Institutional Trading of Snowflake
Large investors have recently made changes to their positions in the company. Kemnay Advisory Services Inc. acquired a new stake in shares of Snowflake in the 4th quarter valued at about $28,000. Greenline Wealth Management LLC acquired a new stake in shares of Snowflake in the 4th quarter valued at about $29,000. GoalVest Advisory LLC grew its stake in shares of Snowflake by 221.4% in the 4th quarter. GoalVest Advisory LLC now owns 135 shares of the company’s stock valued at $30,000 after buying an additional 93 shares during the period. Physician Wealth Advisors Inc. grew its stake in shares of Snowflake by 56.0% in the 4th quarter. Physician Wealth Advisors Inc. now owns 142 shares of the company’s stock valued at $31,000 after buying an additional 51 shares during the period. Finally, Emerald Advisers LLC grew its stake in shares of Snowflake by 95.2% in the 1st quarter. Emerald Advisers LLC now owns 205 shares of the company’s stock valued at $31,000 after buying an additional 100 shares during the period. 65.10% of the stock is currently owned by institutional investors and hedge funds.
Trending Headlines about Snowflake
Here are the key news stories impacting Snowflake this week:
- Positive Sentiment: Needham raised its price target on Snowflake to $330 and BTIG lifted its target to $325, with both firms keeping buy ratings, reinforcing Wall Street’s confidence in upside from current levels.
- Positive Sentiment: TD Cowen reaffirmed a buy rating and set a $300 target, adding to a broader cluster of analyst support following Snowflake’s strong quarterly results.
- Positive Sentiment: Coverage around Snowflake’s latest quarter remains favorable, with commentary highlighting accelerating product adoption, especially for AI-native products like Snowflake Intelligence and Cortex Code, which is helping support the bull case. Microsoft Build 2026 Is Really Just One Big AI Stress Test (SNOW)
- Positive Sentiment: Snowflake’s Summit 26 announcements and partner ecosystem updates underscore growing enterprise demand for its AI data cloud, including new integrations, marketplace launches, and awards for partners such as NIQ, BlueCloud, and others.
- Neutral Sentiment: Several articles framed Snowflake as a major AI beneficiary and discussed its expanding partnerships with Anthropic, AWS, and enterprise customers, which may help long-term growth but are still being digested by investors.
- Negative Sentiment: Recent insider sales by directors Frank Slootman and Mark Garrett could act as a mild overhang, even though the transactions were disclosed and, in Slootman’s case, executed under a pre-arranged trading plan.
About Snowflake
Snowflake Inc is a cloud-native data platform company that provides a suite of services for storing, processing and analyzing large volumes of data. Its core offering, often described as the Snowflake Data Cloud, combines data warehousing, data lake and data sharing capabilities in a single managed service delivered across major public cloud providers. The platform is designed to support analytics, data engineering, data science and application workloads with a focus on scalability, concurrency and simplified administration.
Key products and capabilities include a multi-cluster, shared-data architecture that separates compute from storage; continuous data ingestion and streaming; support for structured and semi-structured data formats; tools for data governance, security and compliance; and developer frameworks for building data applications.
Featured Articles
- Five stocks we like better than Snowflake
- Microsoft Build 2026 Is Really Just One Big AI Stress Test
- Slice of the Pie: Why Yum’s Deal Lifts QSR
- 3 Most Upgraded Stocks Last Month According to MarketBeat
- MongoDB Is the Latest SaaS Apocalypse Victim to Say “Not Today”
Receive News & Ratings for Snowflake Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Snowflake and related companies with MarketBeat.com's FREE daily email newsletter.
